BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 22484185)

  • 1. Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitors.
    Kudchadkar R; Lewis K; Gonzalez R
    Semin Oncol; 2012 Apr; 39(2):139-44. PubMed ID: 22484185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway.
    Sekulic A; Mangold AR; Northfelt DW; LoRusso PM
    Curr Opin Oncol; 2013 May; 25(3):218-23. PubMed ID: 23493193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal cell carcinomas: attack of the hedgehog.
    Epstein EH
    Nat Rev Cancer; 2008 Oct; 8(10):743-54. PubMed ID: 18813320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal cell carcinoma: hedgehog pathway inhibitors and beyond.
    Walls B
    Cutis; 2013 Jun; 91(6):E1-4. PubMed ID: 23837158
    [No Abstract]   [Full Text] [Related]  

  • 5. Small Molecule Inhibitors of the Hedgehog Pathway in the Treatment of Basal Cell Carcinoma of the Skin.
    Danhof R; Lewis K; Brown M
    Am J Clin Dermatol; 2018 Apr; 19(2):195-207. PubMed ID: 28887802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal cell carcinoma: a paradigm for targeted therapies.
    Dreier J; Felderer L; Barysch M; Rozati S; Dummer R
    Expert Opin Pharmacother; 2013 Jul; 14(10):1307-18. PubMed ID: 23656611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular genetics underlying basal cell carcinoma pathogenesis and links to targeted therapeutics.
    Iwasaki JK; Srivastava D; Moy RL; Lin HJ; Kouba DJ
    J Am Acad Dermatol; 2012 May; 66(5):e167-78. PubMed ID: 20800318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hedgehog signaling in basal cell carcinoma.
    Otsuka A; Levesque MP; Dummer R; Kabashima K
    J Dermatol Sci; 2015 May; 78(2):95-100. PubMed ID: 25766766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sonic Hedgehog Pathway Inhibition in the Treatment of Advanced Basal Cell Carcinoma.
    Leavitt E; Lask G; Martin S
    Curr Treat Options Oncol; 2019 Nov; 20(11):84. PubMed ID: 31773379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Targeted therapy of basal cell carcinoma through inhibition of the hedgehog signaling pathway].
    Hafner C
    Hautarzt; 2010 Apr; 61(4):356-8. PubMed ID: 20309511
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeting the hedgehog pathway to treat basal cell carcinoma.
    Geeraert P; Williams JS; Brownell I
    J Drugs Dermatol; 2013 May; 12(5):519-23. PubMed ID: 23652945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vismodegib: a hedgehog pathway inhibitor for locally advanced and metastatic basal cell carcinomas.
    Sobanko JF; Okman J; Miller C
    J Drugs Dermatol; 2013 Oct; 12(10 Suppl):s154-5. PubMed ID: 24085062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vismodegib: an inhibitor of the Hedgehog signaling pathway in the treatment of basal cell carcinoma.
    Proctor AE; Thompson LA; O'Bryant CL
    Ann Pharmacother; 2014 Jan; 48(1):99-106. PubMed ID: 24259609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vismodegib and the hedgehog pathway: a new treatment for basal cell carcinoma.
    Cirrone F; Harris CS
    Clin Ther; 2012 Oct; 34(10):2039-50. PubMed ID: 23036338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hedgehog signaling in skin cancers.
    Li C; Chi S; Xie J
    Cell Signal; 2011 Aug; 23(8):1235-43. PubMed ID: 21397013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hedgehog- and mTOR-targeted therapies for advanced basal cell carcinomas.
    Piérard-Franchimont C; Hermanns-Lê T; Paquet P; Herfs M; Delvenne P; Piérard GE
    Future Oncol; 2015 Nov; 11(22):2997-3002. PubMed ID: 26437034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Primary Cilia Drives Switching from Hedgehog to Ras/MAPK Pathway in Resistant Basal Cell Carcinoma.
    Kuonen F; Huskey NE; Shankar G; Jaju P; Whitson RJ; Rieger KE; Atwood SX; Sarin KY; Oro AE
    J Invest Dermatol; 2019 Jul; 139(7):1439-1448. PubMed ID: 30707899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Practical Guide for the Follow-Up of Patients with Advanced Basal Cell Carcinoma During Treatment with Hedgehog Pathway Inhibitors.
    Dessinioti C; Plaka M; Soura E; Mortaki D; Papaxoinis G; Gogas H; Stratigos AJ
    Oncologist; 2019 Aug; 24(8):e755-e764. PubMed ID: 31073024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle.
    Hutchin ME; Kariapper MS; Grachtchouk M; Wang A; Wei L; Cummings D; Liu J; Michael LE; Glick A; Dlugosz AA
    Genes Dev; 2005 Jan; 19(2):214-23. PubMed ID: 15625189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond the scalpel: targeting hedgehog in skin cancer prevention.
    Rudin CM
    Cancer Prev Res (Phila); 2010 Jan; 3(1):1-3. PubMed ID: 20051365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.